Ropinirole 24-hour prolonged-release adjunctive therapy improves cardinal symptoms in patients with advanced Parkinson's disease not optimally controlled with L-dopa

被引：0

|

作者：

Isaacson, S.

Pahwa, R.

Earl, N.

机构：

来源：

PARKINSONISM & RELATED DISORDERS | 2007年 / 13卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S108 / S108

页数：1

相关论文

共 50 条

[21] Ropinirole Prolonged Release Reduces Significant Sleep Disturbance in Patients with Advanced Parkinson's Disease (PD) Not Optimally Controlled with L-dopa
Chaudhuri, K.
Giorgi, Luigi
Statham, Julia
NEUROLOGY, 2009, 72 (11) : A115 - A115
[22] Adjunctive ropinirole 24-hour prolonged release compared with ropinirole immediate release in patients with advanced Parkinson's disease (PD): the PREPARED study
Stocchi, F.
Hunter, B.
Giorgi, L.
Schapira, A. H. V.
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 134 - 134
[23] Ropinirole prolonged release maintains a positive treatment response in patients with advanced Parkinson's disease (PD) not optimally controlled with L-Dopa
Ruzicka, E.
Hunter, B.
Giorgi, L.
Hersh, B.
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 522 - 522
[24] Nocturnal symptoms are improved with ropinirole prolonged release in patients with advanced Parkinson's disease (PD) with significant night-time symptoms not optimally controlled with L-dopa
Chaudhuri, K. R.
Giorgi, L.
Statham, J.
Reichmann, H.
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 520 - 520
[25] Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease
Pahwa, R.
Stacy, M. A.
Factor, S. A.
Lyons, K. E.
Stocchi, F.
Hersh, B. P.
Elmer, L. W.
Truong, D. D.
Earl, N. L.
NEUROLOGY, 2007, 68 (14) : 1108 - 1115
[26] Ropinirole 24-hour prolonged release improves sleep disturbance, but does not increase daytime somnolence in patients with advanced Parkinson's disease when administered as adjunctive therapy
Isaacson, S.
Stocchi, F.
Earl, N.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S108 - S108
[27] Safety and tolerability of ropinirole 24-hour prolonged release in patients with early and advanced Parkinson's disease
Stocchi, F.
Hersh, B. P.
Earl, N. L.
Scott, B. L.
MOVEMENT DISORDERS, 2006, 21 : S572 - S572
[28] Safety and tolerability of ropinirole 24-hour prolonged release in patients with early and advanced Parkinson's disease
Stocchi, F.
Hersh, B. P.
Giorgi, L.
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 76 - 76
[29] Comparison of adjunctive ropinirole 24-hour prolonged release and ropinirole immediate release in patients with advanced Parkinson's disease: A per-protocol analysis of the PREPARED study
Schapira, A. H. V.
Stocchi, F.
Hunter, B.
Giorgi, L.
MOVEMENT DISORDERS, 2008, 23 (01) : S196 - S197
[30] Ropinirole prolonged release reduces nocturnal symptoms in patients with advanced Parkinson's disease (PD) with significant night-time symptoms not optimally controlled with L-dopa: PDSS items analysis
Chaudhuri, K. R.
Giorgi, L.
Statham, J.
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 549 - 549

← 1 2 3 4 5 →